Quantcast

Latest Multi-drug-resistant tuberculosis Stories

2014-07-29 08:31:43

Program to Enable Broader Access to Groundbreaking Tuberculosis Diagnostic SUNNYVALE, Calif., July 29, 2014 /PRNewswire/ -- With the recent completion of a record shipment of 774 GeneXpert systems to a single country in one quarter, Cepheid (Nasdaq: CPHD) today applauded groundbreaking tuberculosis programs in China where more than a million new cases of tuberculosis (TB) are reported each year. Combined with systems placed previously, the second quarter placements bring the...

2014-07-03 12:54:25

European Lung Foundation The World Health Organization (WHO) today, together with the European Respiratory Society (ERS), presented a new framework to eliminate tuberculosis (TB) in countries with low levels of the disease. Today there are 33 countries and territories where there are fewer than 100 TB cases per million population. The framework outlines an initial "pre-elimination" phase, aiming to have fewer than 10 new TB cases per million people per year by 2035 in these countries....

2014-06-10 23:02:02

Promoting the Quality of Medicines (PQM) program helps attain WHO approval for treatment of drug resistant TB. Rockville, MD (PRWEB) June 10, 2014 The US Pharmacopeial Convention (USP) is pleased to announce that with the assistance of the U.S. Agency for International Development (USAID) funded Promoting the Quality of Medicines (PQM) program, the first Active Pharmaceutical Ingredient (API) for injectables used in the treatment of multi-drug resistant tuberculosis has been assessed by...

2014-04-23 16:29:42

Partnership Supports Newly Announced STAND Trial SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- TB Alliance, an international non-profit drug development organization that develops better, faster-acting, and affordable tuberculosis (TB) drugs, has announced that it is collaborating with, and has granted an exclusive license to, the Shanghai Fosun Pharmaceutical Development Co., Ltd., and its subsidiary Shenyang Hongqi Pharmaceutical Co., Ltd. (Fosun Pharma), to develop and...

2014-04-23 16:29:39

STAND trial will test the first regimen designed to significantly shorten and simplify the treatment of drug-sensitive and drug-resistant TB SEATTLE, April 23, 2014 /PRNewswire-USNewswire/ -- Based on positive results from earlier clinical studies, TB Alliance is advancing the first-ever drug regimen designed to treat both drug-sensitive and some forms of multi-drug resistant tuberculosis (TB) to a global Phase 3 clinical trial. The announcement by Bill Gates, co-chair of the Bill...

2014-04-02 23:32:49

Presentation details three separate tuberculosis immunotherapies developed by Immunitor in collaboration with academic institutions and private companies in Mongolia, China, Thailand, Ukraine, UK, USA and Canada. Data presented support the Immunitor strategy to target inflammation as the main cause of TB and development of immunomodulators and therapeutic vaccines which demonstrate ability to rapidly clear TB, including MDR-TB and TB with HIV. Vancouver, BC, Canada (PRWEB) April 02, 2014...

Bringing Attention To The Threat Of Tuberculosis On World TB Day
2014-03-24 07:49:51

Lawrence LeBlond for redOrbit.com - Your Universe Online Global partnerships and significant medical research are a big part of this year’s World Tuberculosis Day. Celebrated each year on March 24, World TB Day is a marked as a time to bring attention to the threat of tuberculosis, a disease that affects nearly nine million people a year. WHO For the World Health Organization (WHO), this year’s slogan for World TB Day is “Reach 3 Million.” Despite TB’s curability, efforts...

2014-03-20 23:03:06

Dr. Kwonjune Justin Seung, Medical Director of the Eugene Bell Foundation, has joined the Core Group of the Global Drug-resistant Tuberculosis Initiative of the World Health Organization. Washington. DC (PRWEB) March 20, 2014 The Eugene Bell Foundation’s Medical Director, Dr. Kwonjune Justin Seung has been appointed to the World Health Organization’s newly formed Core Group of the Global Drug-resistant Tuberculosis Initiative (GDI). GDI’s mission is to combat multidrug-resistant...

2014-03-20 12:33:41

Thousands receive treatment prior to coming to the United States ATLANTA, March 20, 2014 /PRNewswire-USNewswire/ -- Updated CDC recommendations for overseas tuberculosis (TB) screening of immigrants and refugees have identified hundreds of cases that otherwise would have gone undetected until after arrival in the United States, saving taxpayers an additional $15 million in medical costs. In 2012, the most recent year for which data are available, overseas physicians identified more...

2014-03-20 04:21:53

BEIJING and HILDEN, Germany, March 20, 2014 /PRNewswire/ -- - QuantiFERON-TB, the leading modern test for accurate diagnosis of latent tuberculosis infections, continues to grow rapidly around the world - Commercial launch of QuantiFERON-TB in China, where latent TB affects an estimated 41% of population, will support nationwide efforts to control TB - QIAGEN marks World TB Day 2014 on March 24 with QuantiFERON-TB...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.